|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: BIOSANTE PHARMACEUTICALS INC, 10QSB, EX-10.1, 2000-08-11 |
Next: NAVIDEC INC, 8-K, 2000-08-11 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 3,666
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 3,406
<PP&E> 657
<DEPRECIATION> 232
<TOTAL-ASSETS> 3,831
<CURRENT-LIABILITIES> 247
<BONDS> 0
0
0
<COMMON> 17,676
<OTHER-SE> (14,092)
<TOTAL-LIABILITY-AND-EQUITY> 3,831
<SALES> 0
<TOTAL-REVENUES> 122
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 2,012
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (1,890)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,890)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,890)
<EPS-BASIC> (.03)
<EPS-DILUTED> (.03)
</TABLE>
|
|